Polarization of tumor-associated macrophage phenotype via porous hollow iron nanoparticles for tumor immunotherapy in vivo.

Tumor-associated macrophages (TAMs) are the most important components in the tumor immunosuppressive microenvironment, promoting tumor growth and metastasis. Although TAMs have become one of the hot topics of tumor immunotherapy, challenges still remain to achieve TAM-targeted re-polarization therapy. In this work, porous hollow iron oxide nanoparticles (PHNPs) were synthesized for loading a P13K γ small molecule inhibitor (3-methyladenine, 3-MA) and further modified by mannose to target TAMs. The delivery system named PHNPs@DPA-S-S-BSA-MA@3-MA showed good efficiency for targeting TAMs. The inflammatory factor NF-κB p65 of macrophages was activated by the combination of PHNPs and 3-MA, which synergistically switched TAMs to pro-inflammatory M1-type macrophages. As a result, it activated immune responses and inhibited tumor growth in vivo. The study provides an intracellular switch of the TAM phenotype for targeted TAM therapy.

[1]  Will Liao,et al.  The cellular and molecular origin of tumor-associated macrophages , 2014, Science.

[2]  G. Vunjak‐Novakovic,et al.  Controlled release of cytokines using silk-biomaterials for macrophage polarization. , 2015, Biomaterials.

[3]  Chen Huang,et al.  Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN/PI3Kγ to Promote Pancreatic Cancer Metastasis. , 2018, Cancer research.

[4]  S. Sant,et al.  Hypoxic tumor microenvironment: Opportunities to develop targeted therapies. , 2016, Biotechnology advances.

[5]  Brian Ruffell,et al.  Macrophages and therapeutic resistance in cancer. , 2015, Cancer cell.

[6]  Morteza Mahmoudi,et al.  Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. , 2016, Nature nanotechnology.

[7]  Ting Liu,et al.  Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxia. , 2016, ACS nano.

[8]  Chenjie Xu,et al.  Porous hollow Fe(3)O(4) nanoparticles for targeted delivery and controlled release of cisplatin. , 2009, Journal of the American Chemical Society.

[9]  Jeffrey W. Pollard,et al.  Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.

[10]  C. Lewis,et al.  Macrophage regulation of tumor responses to anticancer therapies. , 2013, Cancer cell.

[11]  Jeffrey W Pollard,et al.  Tumor-associated macrophages: from mechanisms to therapy. , 2014, Immunity.

[12]  H. Byrne,et al.  Dual Targeted Immunotherapy via In Vivo Delivery of Biohybrid RNAi‐Peptide Nanoparticles to Tumor‐Associated Macrophages and Cancer Cells , 2015, Advanced functional materials.

[13]  Melody A Swartz,et al.  Engineering opportunities in cancer immunotherapy , 2015, Proceedings of the National Academy of Sciences.

[14]  Jonathan B. Mitchem,et al.  Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. , 2013, Cancer research.

[15]  Xingzhong Zhao,et al.  Myeloid‐Derived Suppressor Cell Membrane‐Coated Magnetic Nanoparticles for Cancer Theranostics by Inducing Macrophage Polarization and Synergizing Immunogenic Cell Death , 2018, Advanced Functional Materials.

[16]  Bing Li,et al.  Expression of Adipocyte/Macrophage Fatty Acid-Binding Protein in Tumor-Associated Macrophages Promotes Breast Cancer Progression. , 2018, Cancer research.

[17]  D. Durden,et al.  A Macrophage-Dominant PI3K Isoform Controls Hypoxia-Induced HIF1α and HIF2α Stability and Tumor Growth, Angiogenesis, and Metastasis , 2014, Molecular Cancer Research.

[18]  P. Cheng,et al.  Macrophage PTEN Regulates Expression and Secretion of Arginase I Modulating Innate and Adaptive Immune Responses , 2014, The Journal of Immunology.

[19]  K. Cai,et al.  Tumor acidity activating multifunctional nanoplatform for NIR-mediated multiple enhanced photodynamic and photothermal tumor therapy. , 2018, Biomaterials.

[20]  Yifan Ma,et al.  Tumor associated macrophage-targeted microRNA delivery with dual-responsive polypeptide nanovectors for anti-cancer therapy. , 2017, Biomaterials.

[21]  J. Wargo,et al.  Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy , 2017, Cell.

[22]  N. Zhang,et al.  Mannan-Modified Solid Lipid Nanoparticles for Targeted Gene Delivery to Alveolar Macrophages , 2010, Pharmaceutical Research.

[23]  Youssef W. Naguib,et al.  Tumor-Associated Macrophage-Mediated Targeted Therapy of Triple-Negative Breast Cancer. , 2016, Molecular pharmaceutics.

[24]  Zhuang Liu,et al.  Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses , 2017, Nature Communications.

[25]  G. Natoli,et al.  Macrophages and cancer: from mechanisms to therapeutic implications. , 2015, Trends in immunology.

[26]  X. Gou,et al.  MicroRNA-26b Modulates the NF-κB Pathway in Alveolar Macrophages by Regulating PTEN , 2015, The Journal of Immunology.

[27]  L. Recht,et al.  The Promise of Targeting Macrophages in Cancer Therapy , 2017, Clinical Cancer Research.

[28]  K. Cai,et al.  A pH/ROS Cascade‐Responsive Charge‐Reversal Nanosystem with Self‐Amplified Drug Release for Synergistic Oxidation‐Chemotherapy , 2018, Advanced science.

[29]  Nanfei Yang,et al.  Caspase-1 cleaves PPARγ for potentiating the pro-tumor action of TAMs , 2017, Nature Communications.

[30]  D. F. Barber,et al.  Polyethylenimine-coated SPIONs trigger macrophage activation through TLR-4 signaling and ROS production and modulate podosome dynamics. , 2015, Biomaterials.

[31]  Muthu Kumara Gnanasammandhan,et al.  In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers , 2012, Nature Medicine.

[32]  You-hong Cui,et al.  Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth , 2017, Nature Communications.

[33]  Yanfeng Luo,et al.  Size/Charge Changeable Acidity‐Responsive Micelleplex for Photodynamic‐Improved PD‐L1 Immunotherapy with Enhanced Tumor Penetration , 2018 .

[34]  K. Cai,et al.  Multifunctional Fe2O3@PPy-PEG nanocomposite for combination cancer therapy with MR imaging , 2015, Nanotechnology.

[35]  S. Senju,et al.  Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment. , 2018, Cancer research.

[36]  Chun Li,et al.  A targeted approach to cancer imaging and therapy. , 2014, Nature materials.

[37]  G. Dranoff,et al.  Combining immunotherapy and targeted therapies in cancer treatment , 2012, Nature Reviews Cancer.

[38]  Q. Luo,et al.  Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages. , 2017, ACS nano.

[39]  Mengyu Guo,et al.  Tailoring Nanomaterials for Targeting Tumor‐Associated Macrophages , 2019, Advanced materials.

[40]  J. Pollard.  Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.

[41]  R. Weinberg,et al.  Understanding the tumor immune microenvironment (TIME) for effective therapy , 2018, Nature Medicine.

[42]  R. Jain,et al.  Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy , 2012, Proceedings of the National Academy of Sciences.

[43]  J. Yewdell,et al.  Enhancing responses to cancer immunotherapy , 2018, Science.

[44]  J. Kutok,et al.  Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells , 2016, Nature.

[45]  Philippe Foubert,et al.  PI3Kγ is a molecular switch that controls immune suppression , 2016, Nature.

[46]  H. Ran,et al.  Engineering of a Nanosized Biocatalyst for Combined Tumor Starvation and Low-Temperature Photothermal Therapy. , 2018, ACS nano.

[47]  Yan Hu,et al.  β-Cyclodextrin conjugated magnetic nanoparticles for diazepam removal from blood. , 2011, Chemical communications.

[48]  Brian Ruffell,et al.  Macrophages as regulators of tumour immunity and immunotherapy , 2019, Nature Reviews Immunology.